BioSpace News Archive

Drug Development

Intercept Announces Phase III REVERSE Trial Evaluating OCA for the Treatment of NASH Patients With Compensated Cirrhosis

REVERSE is a randomized, double-blind, placebo-controlled, multi-center study that will evaluate the efficacy and safety of the investigational therapy OCA in approximately 540 patients with a biopsy-confirmed diagnosis of cirrhosis due to NASH.

February 12, 2018

·

7 min read

Biotech Beach

Capricor to Give Update on HOPE-2 Clinical Trial for CAP-1002 at International Conference on Duchenne Muscular Dystrophy

The three-day conference brings together scientists, physicians, companies, patients and their families to discuss the latest developments in Duchenne and Becker muscular dystrophy.

February 12, 2018

·

4 min read

Business

Spring Bank to Host Conference Call to Discuss Fourth Quarter and Fiscal Year 2017 Results on Wednesday, February 21

The company will provide its 2018 development outlook at 8:30am Eastern Time on Wednesday, February 21, 2018.

February 12, 2018

·

1 min read

Pharm Country

Actinium Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record

To be a shareholder of record, ownership of Actinium stock must occur by market close of February 12, 2018 to account for settlement.

February 12, 2018

·

8 min read

Business

Horizon Discovery Enters into License Agreement With U.S. Immuno-Oncology Company

Horizon has licensed to the Partner a novel cell line engineering technology as well as non-exclusive rights to Horizon’s proprietary Helitron transposon gene editing technology for an undisclosed financial consideration.

February 12, 2018

·

6 min read

Drug Development

Allergy Therapeutics: Completion of Recruitment in PQ Grass Phase II Trial

Trial running ahead of schedule with data now due in early H2 2018.

February 12, 2018

·

3 min read

Lone Star Bio

Stephens & Associates’ Clinical and Business Teams Will be Attending the American Academy of Dermatology’s Annual Meeting in San Diego

The clinical research teams and business leaders from both the Dallas and Phoenix centers will be attending the 2018 American Academy of Dermatology Annual Meeting from February 16 through 20 at the San Diego Convention Center.

February 12, 2018

·

2 min read

Business

Aerie Pharmaceuticals Announces Appointment of Scott Cassady as Regional Sales Director for the Central Region

Aerie announced the appointment of Scott Cassady as Regional Sales Director for the Central Region, reporting to Gary Menichini, Aerie’s Vice President of Sales.

February 12, 2018

·

5 min read

Biotech Bay

NovaBay Pharmaceuticals Completes $6M Private Placement

NovaBay Pharmaceuticals announces the completion of a private placement of 1.7 million shares of common stock to OP Financial Investments Limited for gross proceeds of $5,984,000.

February 12, 2018

·

4 min read

Business

Medicenna Reports Third Quarter Fiscal 2018 Financial Results

Medicenna today reported financial results for the three and nine months ended December 31, 2017.

February 12, 2018

·

10 min read